Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy : Interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents

Archives of General Psychiatry

Volumn 65, Issue 7, 2008, Pages 795-803

  De Abajo, Francisco J ^a   Garcia Rodriguez, Luis A ^b  

^a Department of Human Use Medicines   (Spain)

^b Department of Pharmacoepidemiology   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CITALOPRAM; CLOMIPRAMINE; CLOPIDOGREL; CORTICOSTEROID; DIPYRIDAMOLE; DOSULEPIN; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; IMIPRAMINE; LOFEPRAMINE; MAPROTILINE; MIRTAZAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TICLOPIDINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE MALEATE; UNINDEXED DRUG; VENLAFAXINE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONSULTATION; CONTROLLED STUDY; DATA BASE; DIGESTIVE SYSTEM PERFORATION; DISEASE ASSOCIATION; FEMALE; GENERAL PRACTICE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK; UPPER GASTROINTESTINAL BLEEDING;

ADULT; AGED; AGED, 80 AND OVER; ANTACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; CHLORATES; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS;

EID: 46849119197     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.65.7.795     Document Type: Article

References (38)

1. Paton C, Ferrier IN. SSRIs and gastrointestinal bleeding. BMJ. 2005;331(7516):529-530.
2. Turner MS, May DB, Arthur RR, Xiong GL. Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks. J Intern Med. 2007;261(3):205-213.
3. Humphries JE, Wheby MS, VandenBerg SR. Fluoxetine and the bleeding time. Arch Pathol Lab Med. 1990;114(7):727-728.
4. Alderman CP, Moritz CK, Ben-Tovim DL. Abnormal platelet aggregation associated with fluoxetine therapy. Ann Pharmacother. 1992;26(12):1517-1519.
5. Calhoun JW, Calhoun DD. Prolonged bleeding time in a patient treated with sertraline [letter]. Am J Psychiatry. 1996;153(3):443.
6. Ottervanger JP, Stricker BHCH, Huls J, Weeda JN. Bleeding attributed to the intake of paroxetine. Am J Psychiatry. 1994;151(5):781-782.
7. de Abajo FJ, Montero D, Rodríguez LA, Madurga M. Antidepressants and risk of upper gastrointestinal bleeding. Basic Clin Pharmacol Toxicol. 2006;98(3):304-310.
8. de Abajo FJ, Rodríguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ. 1999;319(7217):1106-1109.
9. Van Walraven C, Mamdami MM, Wells PS, Williams JI. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ. 2001;22(7314):655-658.
10. Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med. 2003;163(1):59-64.
11. Wessinger S, Kaplan M, Choi L, Williams M, Lau C, Sharp LK, Crowell MD, Keshavarzian A, Jones MP. Increased use of selective serotonin reuptake inhibitors in patients admitted with acute gastrointestinal hemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther. 2006;23(7):937-944.
12. Dunn NR, Pearce GL, Shakir SA. SSRIs are not more likely than other drugs to cause such bleeding. BMJ. 2000;320(7246):1405-1406.
13. Tata LJ, Fortun PJ, Hubbard RB, Smeeth L, Hawkey CJ, Smith CJ, Whittaker HJ, Farrington CP, Card TR, West J. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther. 2005;22(3):175-181.
14. Yuan Y, Tsoi K, Hunt RH. Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding? Am J Med. 2006;119(9):719-727.
15. Kohn S, Labbate LA. Venlafaxine and ecchymosis [letter]. Can J Psychiatry. 1997;42(1):91.
16. Sarma A, Horne MK III. Venlafaxine-induced ecchymoses and impaired platelet aggregation. Eur J Haematol. 2006;77(6):533-537.
17. García-Rodríguez LA, Barreales Tolosa L. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology. 2007;132(2):498-506.
18. Rothman K. Epidemiology: An Introduction. Oxford, England: Oxford University Press; 2002.
19. Tatsumi M, Groshan K, Blakely RD, Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997;340(2-3):249-258.
20. Bjerre LM, LeLorier J. Expressing the magnitude of adverse effects in case-control studies: the number of patients needed to be treated for one additional patient to be harmed. BMJ. 2000;320(7233):503-504.
21. Hernández-Díaz S, Rodríguez LA. Incidence of serious upper gastrointestinal bleeding/perforation in the general population. J Clin Epidemiol. 2002;55(2):157-163.
22. Opatrny L, Delaney JA, Suissa S. Gastrointestinal bleed risk with the use of selective serotonin receptor antagonists: a new look [abstract 017]. Pharmacoepidemiol Drug Saf. 2007;16(suppl):S8.
23. Helin-Salmivaara A, Huttunen T, Grönroos JM, Klaukka T, Huupponen R. Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population. Eur J Clin Pharmacol. 2007;63(4):403-408.
24. Lewis JD, Strom BL, Localio AR, Metz DC, Farrar JT, Weinrieb RM, Nessel L, Brensinger C, Kimmel SE. Moderate to high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity. Pharmacoepidemiol Drug Saf. 2008;17(4):328-335.
25. Vidal X, Ibáñez L, Vendrell L, Conforti A, Laporte JR; Spanish-Italian Collaborative Group for the Epidemiology of Gastrointestinal Bleeding. Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antide-pressants: a case-control study. Drug Saf. 2008;31(2):159-168.
26. Layton D, Clark DW, Pearce GL, Shakir SA. Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol. 2001;57(2):167-176.
27. Movig KL, Janssen MW, de Waal Malefijt J, Kabel PJ, Leufkens HG, Egberts AC. Relationship of serotoninergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med. 2003;163(19):2354-2358.
28. Meijer WE, Heerdink ER, Nolen WA, Herings RM, Leufkens HG, Egberts AC. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med. 2004;164(21):2367-2370.
29. Ziegelstein RC, Meuchel J, Kim TJ, Latif M, Alvarez W, Dasgupta N, Thombs BD. Selective serotonin reuptake inhibitor use by patients with acute coronary syndromes. Am J Med. 2007;120(6):525-530.
30. Andreasen JJ, Riis A, Hjortdal VE, Jørgensen J, Sørensen HT, Johnsen SP. Effect of selective serotonin reuptake inhibitors on requirements for allogeneic red blood transfusion following coronary artery bypass surgery. Am J Cardiovasc Drugs. 2006;6(4):243-250.
31. de Abajo FJ, Jick H, Derby L, Jick S, Schmitz S. Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol. 2000;50(1):43-47.
32. Bak S, Tsiropoulos I, Kjaersgaard JO, Andersen M, Mellerup E, Hallas J, García-Rodríguez LA, Christensen K, Gaist D. Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke. 2002;33(6):1465-1473.
33. Halperin D, Reber G. Influence of antidepressants on hemostasis. Dialogues Clin Neurosci. 2007;9(1):47-59.
34. Serebruany VL, Gurbel PA, O'Connor CM. Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol Res. 2001;43(5):453-462.
35. Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, Jilma B. Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther. 2000;68(4):435-442.
36. Maurer-Spurej E. Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection. Cell Mol Life Sci. 2005;62(2):159-170.
37. Serebruany VL, Suckow RF, Cooper TB, O'Connor CM, Malinin AI, Krishnan KRR, van Zyl LT, Lekht V, Glassman AH; Sertraline Antidepressant Heart Attack Randomized Trial. Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. Am J Psychiatry. 2005;162(6):1165-1170.
38. Takeuchi K, Tanaka A, Takahira Y, Taniguchi M. Selective serotonin re-uptake inhibitors (SSRIs) aggravate antral ulcers induced by indomethacin in rat stomachs [abstract 337]. Gastroenterology. 2005;128(suppl 2):A48.